CONDENSED BALANCE SHEETS - USD ($)		Sep. 30, 2023	Dec. 31, 2022
Current Assets:
Cash		$ 2,254,493	$ 0
Prepaid expenses		635,334	1,200
Total current assets		2,889,827	1,200
Investments held in Trust Account		515,657,294	0
Deferred offering costs		0	511,395
Total assets		518,547,121	512,595
Current liabilities:
Accrued expenses		322,511	270,391
Liabilities, Current		322,511	503,634
Overfunding Loans		5,000,000	0
Deferred underwriting and advisory fees		17,500,000	0
Total liabilities		22,822,511	503,634
Commitments and contingencies
Shareholders’ equity (deficit)
Class A ordinary shares subject to possible redemption as of September 30, 2023		515,557,294	0
Preference shares, $0.0001 par value; 99,990,000 shares authorized(1); none issued or outstanding	[1]	0	0
Additional paid-in capital		0	23,750
Accumulated deficit		(19,833,934)	(16,039)
Total shareholders’ equity (deficit)		(19,832,684)	8,961	[2]
Total liabilities and shareholders’ equity (deficit)		518,547,121	512,595
Related Party
Current liabilities:
Promissory Note		0	233,243
Common Class A
Shareholders’ equity (deficit)
Ordinary shares	[1]	0	0
Common Class B
Shareholders’ equity (deficit)
Ordinary shares	[1],[3]	$ 1,250	$ 1,250

[1] On April 20, 2023, the Company increased the authorized share capital of the Company. All shares as of December 31, 2022 have been retroactively restated to reflect such increase (see Note 6).

[2] On April 25, 2023, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. All share amounts have been retroactively restated to reflect the share surrender and share recapitalization events (see Note 4).

[3] (2) On April 25, 2023, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. Share amounts as of December 31, 2022 have been retroactively restated to reflect the share surrender and share recapitalization events (see Note 4).